NCT00456625View on ClinicalTrials.gov

Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.

PHASE4CompletedINTERVENTIONAL

Enrollment

76

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Hepatitis B

Interventions

BIOLOGICAL

Engerix™-B

Intramuscular injection, 1 dose

Trial Locations (1)

10330

GSK Investigational Site, Bangkok

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY